Neisseria meningitidis Serogroup X ST-5799 (ST-22 complex) in Turkey: A unique pediatric case

Gönül Tanır; Yasemin Ozsurekci; Jay Lucidarme; Sevgi Yaşar Durmuş; Aiswarya Lekshmi; Özlem Akisoglu; Ahmet Emre Aycan; Raymond Borrow; Mehmet Ceyhan

doi:10.1080/21645515.2017.1377380

Neisseria meningitidis Serogroup X ST-5799 (ST-22 complex) in Turkey: A unique pediatric case

Gönül Tanır, Yasemin Ozsurekci^*, Jay Lucidarme, Sevgi Yaşar Durmuş, Aiswarya Lekshmi, Özlem Akisoglu, Ahmet Emre Aycan, Raymond Borrow, Mehmet Ceyhan

^*Corresponding author for this work

Manchester Meningococcal Reference Unit General

Research output: Contribution to journal › Article › peer-review

4 Citations (Scopus)

Abstract

Although outbreaks of Neisseria meningitidis serogroup X occured in a couple of African countries, a limited number of serogroup X meningococcal cases were reported in America and Europe as well as Turkey. Additionally, serogroup X is still not represented in current conjugated meningococcal vaccines. Here, we describe the first pediatric case with meningitis caused by Neisseria meningitidis serogroup X ST-5799 (ST-22 complex) that formed a distinct lineage.

Original language	English
Pages (from-to)	209-212
Number of pages	4
Journal	Human Vaccines and Immunotherapeutics
Volume	14
Issue number	1
DOIs	https://doi.org/10.1080/21645515.2017.1377380
Publication status	Published - 2 Jan 2018

Bibliographical note

Funding Information:
This publication made use of the Neisseria Multi Locus Sequence Typing website (https://pubmlst.org/neisseria/) developed by Keith Jolley and sited at the University of Oxford (Jolley & Maiden 2010, BMC Bioinformatics, 11:595). The development of this site has been funded by the Wellcome Trust and European Union. This publication made use of the Meningitis Research Foundation Meningococcus Genome Library (http://www.menin gitis.org/research/genome) developed by Public Health England, the Wellcome Trust Sanger Institute and the University of Oxford as a collaboration and funded by Meningitis Research Foundation.

Funding Information:
This publication made use of the Neisseria Multi Locus Sequence Typing website (https://pubmlst.org/neisseria/) developed by Keith Jolley and sited at the University of Oxford (Jolley & Maiden 2010, BMC Bioinformatics, 11:595). The development of this site has been funded by the Wellcome Trust and European Union. This publication made use of the Meningitis Research Foundation Meningococcus Genome Library (http://www.meningitis.org/research/genome) developed by Public Health England, the Wellcome Trust Sanger Institute and the University of Oxford as a collaboration and funded by Meningitis Research Foundation.

Publisher Copyright:
© 2018 Taylor & Francis.

Keywords

Turkey
menengitis
pediatrics
phylogenetic network
sequence analyses

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1080/21645515.2017.1377380

Cite this

@article{081f7d5db7a042a0b5a7d80ece18cb66,

title = "Neisseria meningitidis Serogroup X ST-5799 (ST-22 complex) in Turkey: A unique pediatric case",

abstract = "Although outbreaks of Neisseria meningitidis serogroup X occured in a couple of African countries, a limited number of serogroup X meningococcal cases were reported in America and Europe as well as Turkey. Additionally, serogroup X is still not represented in current conjugated meningococcal vaccines. Here, we describe the first pediatric case with meningitis caused by Neisseria meningitidis serogroup X ST-5799 (ST-22 complex) that formed a distinct lineage.",

keywords = "Turkey, menengitis, pediatrics, phylogenetic network, sequence analyses",

author = "G{\"o}n{\"u}l Tanır and Yasemin Ozsurekci and Jay Lucidarme and {Ya{\c s}ar Durmu{\c s}}, Sevgi and Aiswarya Lekshmi and {\"O}zlem Akisoglu and Aycan, {Ahmet Emre} and Raymond Borrow and Mehmet Ceyhan",

note = "Funding Information: This publication made use of the Neisseria Multi Locus Sequence Typing website (https://pubmlst.org/neisseria/) developed by Keith Jolley and sited at the University of Oxford (Jolley & Maiden 2010, BMC Bioinformatics, 11:595). The development of this site has been funded by the Wellcome Trust and European Union. This publication made use of the Meningitis Research Foundation Meningococcus Genome Library (http://www.menin gitis.org/research/genome) developed by Public Health England, the Wellcome Trust Sanger Institute and the University of Oxford as a collaboration and funded by Meningitis Research Foundation. Funding Information: This publication made use of the Neisseria Multi Locus Sequence Typing website (https://pubmlst.org/neisseria/) developed by Keith Jolley and sited at the University of Oxford (Jolley & Maiden 2010, BMC Bioinformatics, 11:595). The development of this site has been funded by the Wellcome Trust and European Union. This publication made use of the Meningitis Research Foundation Meningococcus Genome Library (http://www.meningitis.org/research/genome) developed by Public Health England, the Wellcome Trust Sanger Institute and the University of Oxford as a collaboration and funded by Meningitis Research Foundation. Publisher Copyright: {\textcopyright} 2018 Taylor & Francis.",

year = "2018",

month = jan,

day = "2",

doi = "10.1080/21645515.2017.1377380",

language = "English",

volume = "14",

pages = "209--212",

journal = "Human Vaccines and Immunotherapeutics",

issn = "2164-5515",

publisher = "Taylor and Francis",

number = "1",

}

TY - JOUR

T1 - Neisseria meningitidis Serogroup X ST-5799 (ST-22 complex) in Turkey

T2 - A unique pediatric case

AU - Tanır, Gönül

AU - Ozsurekci, Yasemin

AU - Lucidarme, Jay

AU - Yaşar Durmuş, Sevgi

AU - Lekshmi, Aiswarya

AU - Akisoglu, Özlem

AU - Aycan, Ahmet Emre

AU - Borrow, Raymond

AU - Ceyhan, Mehmet

N1 - Funding Information: This publication made use of the Neisseria Multi Locus Sequence Typing website (https://pubmlst.org/neisseria/) developed by Keith Jolley and sited at the University of Oxford (Jolley & Maiden 2010, BMC Bioinformatics, 11:595). The development of this site has been funded by the Wellcome Trust and European Union. This publication made use of the Meningitis Research Foundation Meningococcus Genome Library (http://www.menin gitis.org/research/genome) developed by Public Health England, the Wellcome Trust Sanger Institute and the University of Oxford as a collaboration and funded by Meningitis Research Foundation. Funding Information: This publication made use of the Neisseria Multi Locus Sequence Typing website (https://pubmlst.org/neisseria/) developed by Keith Jolley and sited at the University of Oxford (Jolley & Maiden 2010, BMC Bioinformatics, 11:595). The development of this site has been funded by the Wellcome Trust and European Union. This publication made use of the Meningitis Research Foundation Meningococcus Genome Library (http://www.meningitis.org/research/genome) developed by Public Health England, the Wellcome Trust Sanger Institute and the University of Oxford as a collaboration and funded by Meningitis Research Foundation. Publisher Copyright: © 2018 Taylor & Francis.

PY - 2018/1/2

Y1 - 2018/1/2

N2 - Although outbreaks of Neisseria meningitidis serogroup X occured in a couple of African countries, a limited number of serogroup X meningococcal cases were reported in America and Europe as well as Turkey. Additionally, serogroup X is still not represented in current conjugated meningococcal vaccines. Here, we describe the first pediatric case with meningitis caused by Neisseria meningitidis serogroup X ST-5799 (ST-22 complex) that formed a distinct lineage.

AB - Although outbreaks of Neisseria meningitidis serogroup X occured in a couple of African countries, a limited number of serogroup X meningococcal cases were reported in America and Europe as well as Turkey. Additionally, serogroup X is still not represented in current conjugated meningococcal vaccines. Here, we describe the first pediatric case with meningitis caused by Neisseria meningitidis serogroup X ST-5799 (ST-22 complex) that formed a distinct lineage.

KW - Turkey

KW - menengitis

KW - pediatrics

KW - phylogenetic network

KW - sequence analyses

UR - http://www.scopus.com/inward/record.url?scp=85037714712&partnerID=8YFLogxK

U2 - 10.1080/21645515.2017.1377380

DO - 10.1080/21645515.2017.1377380

M3 - Article

C2 - 28933621

AN - SCOPUS:85037714712

SN - 2164-5515

VL - 14

SP - 209

EP - 212

JO - Human Vaccines and Immunotherapeutics

JF - Human Vaccines and Immunotherapeutics

IS - 1

ER -

Neisseria meningitidis Serogroup X ST-5799 (ST-22 complex) in Turkey: A unique pediatric case

Abstract

Bibliographical note

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this